GIMBHI’s daily mental health update — 07/09/26

🧠 Handspring raises $19M Series B to bring mental health care to children and families nationwide (PR Newswire) — 07/08/26
TL;DR: Virtual youth mental health clinic Handspring raised $19M Series B led by RPS Ventures to expand its clinician-first, full-acuity care model—having served 4,000+ families across nine states with 10x revenue growth.

🧠 Virtual ADHD providers pivot toward coaching, therapy following prescription scrutiny (Laura Lovett, Behavioral Health Business) — 07/09/26
TL;DR: After DOJ probes and the Done Global CEO’s prison sentence over illegal Adderall prescribing, virtual ADHD providers like Cerebral, Agave Health, and Shimmer are shifting from medication management toward coaching and therapy.

💊 Phase 2 trial initiated for Briumvi for treatment-resistant schizophrenia (Jessica Walters, Psychiatric Times) — 07/06/26
TL;DR: TG Therapeutics launched an open-label Phase 2 trial testing IV Briumvi (ublituximab) alongside antipsychotics in ~60 adults with treatment-resistant schizophrenia, probing whether B-cell depletion can ease symptoms linked to neuroinflammation.

🏛️ Done Global CEO gets 6 years in prison for Adderall distribution fraud (Ashleigh Hollowell, Behavioral Health Business) — 07/08/26
TL;DR: Done Global founder Ruthia He was sentenced to 6 years in prison and fined $1M for using the ADHD telehealth platform to illegally distribute 37M Adderall pills and defraud insurers of $12M; the former clinical president got 2 years.